Overview

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

Status:
Completed
Trial end date:
1998-09-01
Target enrollment:
Participant gender:
Summary
To compare the single-dose bioavailability of Par and Bristol-Myers Squibb Buspirone HCl Tablets
Phase:
Phase 1
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
Phoenix International Life Sciences, Inc.
Treatments:
Buspirone